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Abstract 
 
Background 
 
Health-related fear is a normal and common response in the face of the global 
pandemic of COVID-19. Children and young people are frequently being exposed to 
messages about the threat to health, including from the media and authorities. Whilst 
for most, their anxiety will be proportionate to the threat, for some, existing 
preoccupation with physical symptoms and illness will become more problematic. 
There is a growing body of evidence that health anxiety may occur in childhood, 
however much of the literature is taken from research using adult samples.  
 
Aims 
 
This practitioner review aims to give an overview of the assessment and 
treatment of health-related worries in children and young people in the context of the 
COVID-19 pandemic. This review is based on the limited existing evidence in this 
population and the more substantial evidence base for treating health anxiety in 
adults. We consider the adaptations needed to ensure such interventions are 
developmentally appropriate.    
 
 
 
 
 
 
 
Keywords: Review; Child; Adolescent; Covid-19 Pandemic; Health Anxiety  
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Worries about health are a common human experience thought to fall along a 
continuum in the general population (Salkovskis & Warwick, 2001).  At the upper end 
of the continuum, individuals experience an obsessive fear of illness (Bilani et al., 
2019) which may fall within the realm of health anxiety. Health anxiety as a 
diagnostic entity is characterised by a preoccupation with either having or developing 
a serious physical illness, which is maintained by behaviours which are designed to 
ameliorate distress, but serve to inadvertently increase or maintain physical 
symptoms and anxiety. Recently changed to ‘Illness Anxiety Disorder’ in the 
Diagnostic Statistical Manual (American Psychiatric Association; APA, 2013) the 
term health anxiety (HA) is still in common use by mental health professionals as this 
also refers to the evidence-based cognitive behavioural model of HA that is used in 
research and clinical settings (Warwick & Salkovskis, 1990; Salkovskis, Warwick & 
Deale, 2003). In this paper, we seek to extrapolate evidence from the HA literature to 
inform how health-related worries in children and young people may be managed in 
practice, and more specifically, how this might relate to infectious disease pandemics 
such as COVID-19.  
   
Health anxiety in children and young people 
 
 HA as a disorder typically presents in early or middle adulthood (APA, 2013; 
Rask et al., 2016). There is some evidence to suggest that HA does occur in 
childhood and adolescence (Eminson, Benjamin, Shortall, Woods, & Faragher, 1996; 
Oliver et al., 2018; Rask, Elberling, Skovgaard, Thomsen, & Fink, 2012; Rask et al., 
2016; Sirri, Ricci Garotti, Grandi, & Tossani, 2015; van Geelen, Rydelius, & 
Hagquist, 2015; Wright & Asmundson, 2003) yet studies examining the prevalence 
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of HA in children and young people suggest that few meet the full diagnostic criteria 
(Rask et al., 2016). This may be partly due to a lack of tailored, developmentally 
appropriate descriptions of how HA presents in children and young people (Fritz, 
Fritsch, & Hagino, 1997; Rask et al., 2016).  
The DSM-5 diagnostic criteria for Illness Anxiety Disorder (previously known 
as HA) specifies that the following symptoms need to be present for at least six 
months: preoccupation with illness, absence of somatic symptoms, hypervigilance of 
own health, self-monitoring for signs of illness, complete avoidance of medical care 
or conversely frequent seeking of medical care (American Psychiatric Association; 
APA, 2013). There are likely to be key differences in the presentation of HA in 
children and young people which relate to stages of development, particularly in 
relation to safety-seeking behaviours and ability to articulate what has precipitated 
the behaviour. For example, the preoccupation with already having or contracting an 
illness may manifest as more generic concerns about health as detailed knowledge 
of disease and disease processes may be absent, especially in younger children. 
Like adults, children may display checking behaviours and seek reassurance directly 
from parents, while adolescents may be more prone to seeking reassurance more 
tacitly from friends or by searching for information online. Avoidance is also likely to 
be present, but the ability to articulate the root of the avoidance is likely to vary 
according to developmental abilities.  
Parental reassurance, acquiescence and inadvertent collusion with safety-
seeking behaviours will serve to maintain anxiety through prevention of 
disconfirmation and the associated physiological and emotional impact of safety-
seeking behaviours we see in adults. Retrospective studies of adults with HA 
indicate that key symptoms, such as fears about becoming unwell, were present in 
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childhood (Fink et al., 2004; Noyes et al., 2002), suggesting that the hallmark 
symptom of HA diagnosis, feeling preoccupied by the idea that one might be ill, is 
present from an early age; we know less about the behavioural maintenance at this 
early age, however we may apply the mechanisms we see in other anxiety disorders. 
Health-related worries and behaviours are common in children and young 
people (Rask et al., 2012; Rask et al., 2016; Sirri et al., 2015; Wright & Asmundson, 
2003), with 15.7% of a sample of 14-19 year-olds reporting “clinically significant 
hypochondriacal symptoms” (Sirri et al., 2015) and the parents of 2.7% of 5-7 year-
olds reporting “considerable” health anxiety symptoms in their children (Rask et al., 
2012). Thus, even though prevalence of HA as a recognised disorder may not have 
been established, health-related worries appear to be relatively common.  
HA has a significant impact on functioning in children and young people; 
health-related anxiety symptoms have been found to be significantly positively 
associated with mental health problems (including emotional disorders, distress and 
somatisation) across a range of age groups (Rask et al., 2012; Rask et al., 2016; 
Sirri et al., 2015). Additionally, younger children with higher levels of HA-related 
symptoms are more likely to present with functional somatic health problems than 
their peers (Rask et al., 2012; Rask et al., 2016). There are also economic costs. 
The medical costs for children with the highest levels of HA-related symptoms have 
been found to be 150 Euros more than those with the lowest levels of HA symptoms 
over a two-year period, even when controlling for physical health conditions (Rask et 
al., 2016).  
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Health related worries in the context of COVID-19 
 
COVID-19 is an infectious disease caused by a novel coronavirus, SARS-
CoV-2 (WHO, 2020a) which, in most cases, results in mild symptoms such as a dry 
cough and fever. In a minority of cases, SARS-CoV-2 can lead to more severe 
complications (including Acute Respiratory Distress Syndrome) and can be fatal 
(Sohrabi et al., 2020). Children and young people are reported to be asymptomatic 
or relatively more mildly affected with few severe cases reported (Lu et al., 2020). 
Since the global spread of COVID-19, and the declaration of a pandemic by 
the World Health Organisation (WHO) on March 11th 2020 (WHO, 2020b), the 
worldwide health context is far from typical. There is a genuine and unprecedented 
threat to health and survival, which results in health concern. This threat is 
compounded by media focus on numbers of positive cases and deaths (Taylor, 
2019) rather than negative cases and recoveries. This is likely to increase public 
perception of risk of contracting the virus, as well as over-estimation of risk if they do 
(Wheaton, Berman, Fabricant & Olatunji, 2012). 
In the face of an unprecedented infectious disease pandemic, it is natural to 
feel anxious and to be concerned about one’s own health and the health of others. 
For most, anxiety will be a proportionate and adaptive response to the threat posed 
by the virus, motivating individuals to engage in sensible, precautionary health 
behaviours (Taylor, 2019). However, for a minority, particularly those who may be 
predisposed to anxiety and/or who lack coping resources, COVID-19 might act as a 
“critical incident” that triggers health related worries. In these individuals ‘normal’ 
health anxiety escalates and becomes distressing, debilitating; while for others, 
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health-related fears are transitory and simmer down once the threat begins to pass. 
It is the former that we focus on in this review.  
 
Health-related worries in children and young people and COVID-19 
 
There are both individual and systematic factors which may render children 
and young people particularly vulnerable to health-related worries in the context of 
COVID-19. It is important to acknowledge that there are key differences in the 
presentation of anxiety between children and adolescents (Waite and Creswell, 
2014), such as the expression of affect through physical sensations in younger 
children. We distinguish between these two groups where possible and where there 
is an evidence base to support such differentiation.  
 
Individual factors – cognitive and developmental 
 
For children and young people, COVID-19 will likely be the first major global 
health threat they will have been exposed to. This may shape or disrupt the 
formation of their emergent beliefs about the world being a ‘safe place’ with regards 
to health. There are a multitude of messages about the omnipresent threat: 
significant changes to behaviour have been enforced, including school closures as 
disease containment measures, alarming public health messages about staying 
home, avoiding people and keeping ‘safe’ being repeatedly communicated through 
various mediums.  
Children’s cognitive ability to process and understand complex information is 
more limited and concrete in comparison to adults (Inhelder, 1958). This makes it 
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more difficult for children to understand abstract information, such as a ‘viral’ health 
related threat. Their emergent beliefs are also more malleable than those of adults 
and are influenced and shaped by significant others (Cantor, Berg, Steyer & Rose, 
2018). Over the course of adolescence, the individual’s own ideas and beliefs 
develop, often influenced by those of peers. Their cognitive abilities develop so that 
they can make sense of the world and events in more abstract, complex ways, and 
can hold several possibilities in mind. Adolescents also are increasingly able to take 
ownership over health relevant behaviours (Turner-Cobb, 2013), however this and 
earlier childhood is a sensitive time in terms of their formative development of their 
understanding of the world.  
 
Individual factors – pre-existing mental health or physical health problems  
 
Some children and young people are more vulnerable to developing health-
related worries in this context due to pre-existing anxiety and/or experiences. In 
university students, prior anxiety sensitivity and obsessive-compulsive symptoms 
and beliefs increased the risk of experiencing pandemic-related anxiety in the 
context of Swine flu (Brand, McKay, Wheaton, & Abramowitz, 2013). This may also 
be relevant for children and young people who have pre-existing anxiety and a 
heightened sense of the world as a ‘dangerous’ place prior to COVID-19. Those who 
experience the death or serious illness of someone in their personal or social 
network as a result of the disease, and those who live with parents who are 
particularly worried about the virus and its impact, may be more vulnerable to 
developing health-related worries.  
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Some children and young people have underlying physical health problems 
which render them more vulnerable to respiratory-type illnesses like COVID-19, 
including those with asthma and the immunosuppressed. These individuals will need 
to take a higher level of precautionary measures to keep ‘safe’; it is these additional 
measures and higher sense of threat of illness that leave them at higher risk of 
ongoing health-related worries. Due to lack of complex cognitive abilities at a young 
age, children may generalise the perception of threat.  
 
Systemic factors – parent and carer mental health  
 
Children’s beliefs about illness and their responses to symptoms are shaped 
by those of significant others, particularly their primary caregivers, most typically their 
parents (Turner-Cobb, 2013). There is evidence of an association between parent 
and child HA symptoms (Koteles, Freyler, Kokonyei, & Bardos, 2015; Remmerswaal 
& Muris, 2011; Marshall, Jones, Ramchandani, Stein, & Bass, 2007; Wright, Reiser, 
& Delparte, 2017). This may arise in several ways. Firstly, a significant proportion of 
learning takes place, particularly at a young age, through observation and imitation 
of significant others. Secondly, the responses of those significant others reinforce 
particular behaviours that the child display (Bandura, 1977). Thus, interacting with 
others is a key social-cognitive process which inevitably shapes the child’s belief 
system.  
Emerging evidence suggests that anxiety levels in adults in the general 
population have increased since ‘lockdown’ (Bentall, 2020), with HA in the adult 
population estimated to have increased by around 10% (Rettie & Daniels, 2020). The 
psychological impact of ‘lockdown’ for adults is likely to be profound and long lasting 
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for many (Brooks et al., 2020). Adults are likely to be experiencing stress and 
general pressures associated with lack of access to normal activities of daily living, 
and financial concerns due to the economic consequences of lockdown (Brooks et 
al., 2020). In addition, many parents have the pressure of home-schooling their 
children whilst also working themselves.  
When parental mental health is compromised, there is undoubtedly some 
degree of impact on the child. This may be directly through modelling of anxious 
behaviour or reduced capacity for the parent to support the child with their own 
anxiety, for example. Indeed, there is a large body of evidence to support the notion 
of intergenerational transmission of anxiety (Lawrence, Murayama, & Creswell, 
2019). This is likely to be further compounded by the curtailed access to both adult 
and child mental health support, and to other supportive adults such as educational 
professionals during school closures.  
 
Assessment 
 
There is a high degree of co-morbidity in anxiety disorders (Creswell, Waite, & 
Cooper, 2014; Kendall et al., 2010; Leyfer, Gallo, Cooper-Vince, & Pincus, 2013) 
and mood disorders (Essau, 2003) across the age range. However, research 
indicates it is possible to separate diagnostic features of different forms of anxiety 
reliably (Spence, 2017). Even though anxiety disorders share transdiagnostic 
processes, they can be separated by their primary focal point of anxiety (Ferdinand, 
Dieleman, Ormel, & Verhulst, 2007), therefore, accurate and thorough assessment is 
imperative to access the right support.  
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In children and young people, a multi-method (including interviews, 
questionnaires and observational approaches) and multi-informant (self-, parent- and 
possibly teacher-report) approach to assessment is recommended (Hudson et al., 
2014; Kazdin, 2003; Silverman & Ollendick, 2005). 
Structured diagnostic interviews are generally considered to be the gold 
standard assessment to identify mental health disorders in children and young 
people (Spence, 2017). These tend to seek information from multiple informants, 
most often the affected child or young person and a parent. The most used 
measures include the Anxiety Disorders Interview Schedule (Silverman & Albano, 
1996) and the Kiddie Schedule of Affective Disorders and Schizophrenia (Kaufman 
et al., 1997), both of which include questions pertaining to health related worries, 
although sections pertaining to a diagnosis of health anxiety are comparatively brief.  
Self-report questionnaires can be useful as a screening tool to complement a 
clinical interview, however there are no specific questionnaires or subscales on 
generic questionnaire which measure HA in children and young people. A version of 
the Illness Attitudes Scale (IAS; Kellner, 1986) has been developed for children, 
although its psychometric properties are yet to be established. Validated and reliable 
self-report measures developed for use in adults may be useful (see Table 1) 
although their psychometric properties in children and young people are unknown. 
There are also several questionnaires which have been developed for research 
purposes to examine parental report of children’s health-related worries, however 
these have not been extensively used in clinical practice (Rask, 2019). These 
include the parent version of the Illness Worry Scale (IWS-p; Garralda & Rangel, 
2001), Fetal Health Anxiety Inventory (Reiser & Wright, 2019) and the protect 
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subscale of the Adult Responses to Children’s Symptoms (ARCS; Van Slyke & 
Walker, 2006) 
Additionally, there are clinician rating scales for HA (see Table 2), although these 
also have not been developed specifically with children and young people in mind.  
 
Table 1 
Self-report Measures of Health Anxiety Developed for Use with Adult 
Populations 
 Health Anxiety 
Inventory, HAI 
(Salkovskis et al., 
2002) 
Illness Attitude Scales, 
IAS (Kellner, 1986) 
Whiteley Index 
(Pilowsky, 
1967) 
Description 64 items 
Each item rated 0 – 3 
29 items 
Each item rated 0 – 4 
9 subscales: worry about 
illness; concerns about 
pain; health habits; 
hypochondriacal beliefs; 
thanatophobia (fear of 
death); disease phobia; 
bodily preoccupations; 
treatment experience; 
effects of symptoms 
14 items 
Dichotomous 
scoring (yes/no) 
 
Total scale 
range 
0 – 192 0 – 108 (only 27 items are 
used for the sum score) 
0 – 14 
 
Other 
versions 
Short version (SHAI) 
– 18 items, total 
scale range of 0 – 54 
CIAS is a version adapted 
for ages 8 – 15 (Wright & 
Anderson, 2003) 
Short version – 
7 item version 
(Fink et al., 
1999) 
Clinical cut-
offs 
HAI: ≥ 67 (Hedman, 
Lekander et al., 
2015); SHAI: ≥ 27 
(Abramowitz, Olatunji 
& Deacon, 2007) 
IAS:  ≥ 45 – 47 (Hiller et 
al., 2002; Hedman, 
Lekander et al., 2015) 
14 item: ≥ 5 – 8 
7 item: ≥ 2.5 – 5 
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Table 2 
Clinician Administered Measures of Health Anxiety 
 
Formulation  
 
The current understanding of HA is primarily informed by cognitive 
behavioural models (Abramowitz, Schwartz, & Whiteside, 2002; Asmundson, 
Carleton, Wright, & Taylor, 2004; Salkovskis, Warwick & Deale, 2003;  Taylor & 
Asmundson, 2004; Warwick & Salkovskis, 1990). Cognitive Behavioural Therapy 
 Rating scale of 
hypochondriacal 
beliefs (Kellner, 
1986) 
 
Heightened illness 
concern severity 
scale (Fallon, 2001) 
 
The modified 
Yale-Brown 
Obsessive-
Compulsive 
Scale for 
Hypochondriasis 
(H-YBOCS-M) 
(Skritskaya et 
al., 2012) 
Description 1 item scale – from 1 
(absent, no concerns 
about physical 
symptoms or illness) 
to 9 (extremely severe 
persistent and 
continuous beliefs 
he/she suffers from a 
physical illness; 
reassurance by a 
physician does not 
alter the belief) 
 
1 item scale – from 1 
(no heightened illness 
concern) to 7 (extreme 
heightened illness 
concern. Amongst the 
most ill of all 
heightened concern 
patients, causing 
extreme distress and 
significant social and 
occupational 
impairment 
19 items looking 
at thoughts, 
behaviours and 
avoidance all 
typical of health 
anxiety 
 
Psychometric 
properties 
Good interrater 
reliability 
 
Is sensitive to change 
(Fallon et al., 2003) 
 
Adequate internal 
consistency and 
is sensitive to 
change. 
Moderately 
correlated with 
the Whiteley 
Index (Skritskaya 
et al., 2012) 
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(CBT) models have the strongest empirical underpinning and evidence base for the 
treatment of anxiety disorders (e.g., see Abramowitz, Moore, Braddock, & 
Harrington, 2009; Marcus, Gurley, Marchi, & Bauer, 2007; Marcus & Norris, 2014; 
Rachman, 2012; Taylor & Asmundson, 2004). The Salkovskis, Warwick and Deale 
(2003) model of HA posits that through experience, health-related beliefs are formed 
which may lead to misappraisal of innocuous bodily states, then further predisposing 
the person to the development of HA. Once established, episodes of HA are usually 
triggered by incoming health-related stimuli, that are interpreted to be a relevant 
threat. This raises anxiety, precipitating use of safety seeking behaviours to reduce 
anxiety and prevent feared health catastrophes, however, these behaviours prevent 
disconfirmation of beliefs and perpetuate this cycle of anxiety.  
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Figure 1 
A Simplified Model of Health Anxiety as Applied to Children and Young People and their Families, Adapted from 
Salkovskis, Warwick & Deale (2003) 
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Figure 1 presents the empirically-grounded CBT formulation for HA in adults 
(Salkovskis, Warwick & Deale, 2003), adapted for children and young people in the 
context of COVID-19. This formulation outlines the interrelated cognitive, 
behavioural, affective and physiological factors in HA outlined above, and includes 
the role of parents in the maintenance of anxiety in children and young people (e.g. 
Murray, Creswell & Cooper, 2009), with further considerations to the wider societal 
context in which the child or young person lives.   
The hypothetical formulation of health anxiety in children and young people 
presented here is drawn from the known characteristics of health anxiety in adults, 
and the empirically grounded evidence-based model of health anxiety in adults. It is 
therefore subject to the inherent limitations of extrapolating mechanisms that 
underpin anxiety in adults to children, and it is within this context the model should 
be considered. Further research is needed to understand the underpinning 
mechanisms that maintain health anxiety in children and young people and the 
adaptations that may be required to accommodate particular developmental stages.  
For children and young people, triggers for anxiety are likely to take the form 
of physical sensations (e.g. urge to cough/coughing) or health threat information 
(e.g. TV programmes, news updates). As children and young people are less likely 
to scrutinise the quality and relevance of incoming information, a threat response 
may be triggered at a lower threshold than adults. Cognitions might typically centre 
around the risk and likelihood of becoming ill with COVID-19, alongside thoughts of 
how catastrophic this could be (i.e. ultimately death of self/parent). Behaviours 
resulting from these health-related fears would be strategically aimed at reducing 
both distress and risk of contracting COVID-19, with the unintended consequence of 
increasing anxiety through prevention of disconfirmation e.g. symptom checking, 
PRACTITIONER REVIEW CHILDREN HEALTH ANXIETY COVID-19                                                  17 
 
 
overly restrictive practices, excessive handwashing. This process also serves to 
increase the perception of worrying physical sensations, through symptom 
hypervigilance for example, or interoceptive experience of physiological arousal 
associated with anxiety. This further acts as a health-related stimuli, elevating 
anxiety and perceived health risk, and so the cycle continues. This is particularly 
problematic due to the limited ability that children may have to understand and 
express their own emotions, therefore the experience of emotions themselves may 
be perceived as threatening. 
Within this adapted formulation we also present key mechanisms between the 
parent and child which may contribute to the maintenance of distress, albeit 
inadvertently. Illness beliefs in the anxious parent trigger safety-seeking strategies 
that are designed to keep both themselves, and the child emotionally and physically 
safe. However, parental safety-seeking behaviours, and the anxiety that underpin 
them, are likely to raise salience of the health threat to the child. This in turn drives 
the child’s own safety-seeking behaviours, which also seek to reduce distress and 
threat to physical health. Parental safety-seeking behaviours are also likely to 
influence the child’s behaviours without an explicit cognitive route e.g. parent 
repeatedly checks for signs of illness, this behaviour is repeated by the child, learned 
via modelling and reinforced by the absence of negative consequences. This, within 
a societal context of public health messages that everyone must stay home in order 
to be safe and keep others safe, and with schools and workplaces closed, may lead 
to intensifying difficult dynamics within the family home.  
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Treatment  
 
Specific interventions for HA in children and young people are lacking. 
Therefore, it may be useful to draw together existing adult treatments which address 
health-related anxiety in complex medical contexts (Daniels, Parker, & Salkovskis, 
2020; Daniels & Sheils, 2017; Tyrer et al., 2017) and established knowledge on how 
psychological treatments are adapted for children and young people. While there is 
research exploring health-related fears during infectious disease outbreaks, this 
does not extend to treatment studies, which are primarily focussed on trauma and 
generic anxiety and depression, so we have little new to learn in this respect. The 
evidence-based model commonly used for HA is described by Salkovskis, Warwick 
& Deale (2003), however this requires adaptation for use with children and young 
people to ensure it is developmentally appropriate (Rask, 2019).  
 
The evidence for Cognitive Behavioural Therapy 
 
There is evidence to support the use of Cognitive Behavioural Therapy (CBT) 
for childhood anxiety, ranging from low intensity interventions (bibliotherapy and E-
therapy) to high intensity interventions (nine to 20 face-to-face sessions: Creswell, 
Waite & Cooper. 2014; Creswell, Waite & Hudson, 2020; James, James, Cowdrey, 
Soler & Choke, 2015). The response to CBT is dependent on the type of anxiety 
presentation; children and adolescents with social anxiety may experience a slower 
rate of change post treatment than those suffering from generalised anxiety (Hudson 
et al., 2015). Studies have tended not to conduct separate trials for children and 
adolescents, despite different presentations in these two groups. Zhou et al. (2019) 
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conducted a network meta-analysis of psychotherapies delivered within a range of 
conditions and modalities e.g. individual and group, internet and face-to-face, with 
and without parental involvement. CBT treatments had the best outcomes in terms of 
quality of life and functioning. Schwartz, Barican, Yung, Zheng, & Waddell (2019) 
conducted a meta-analysis of anxiety interventions for children and found that 10 of 
the 11 CBT interventions evaluated were effective in reducing anxiety in children and 
young people. However, it is important to note that neither of these studies 
specifically focused on health-related worries. 
CBT is effective in treating HA in adults (Cooper, Gregory, Walker, Lambe, & 
Salkovskis, 2017; Hart & Bjorgvinsson, 2010; Newby et al. 2018). A brief five to 10 
sessions of adapted CBT for HA (known as CBT-HA) was effective in improving HA 
symptoms (Tyrer et al., 2014), improvements were sustained over five years and the 
intervention was cost-neutral (Tyrer et al., 2017). CBT has been found to be more 
effective than psychoeducation, clinical support and monitoring (Newby et al., 2018), 
whilst cognitive and exposure-based approaches have also both been found to be 
effective (Weck, Neng, Richtberg, Jakob, & Stangier, 2015). 
We propose that formulation-driven CBT for health-related worries and HA is 
likely the best treatment available for children and young people with HA. This will be 
most effective if adapted to be developmentally appropriate. Creswell, Waite and 
Hudson (2020) suggest that disorder-specific treatments may improve outcomes for 
young people with anxiety, but that evidence-based models need to be developed 
and tested in large clinical trials. In this paper we therefore provide an adaptation of 
the adult disorder-specific model, with developmental considerations. This 
hypothetical model is underpinned by existing research into health-related fear and 
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anxiety in children and young people and draws together what is known to work for 
children with anxiety and adults with health anxiety.   
 
What a CBT intervention for health-related worries with a child or young person 
could involve 
 
The aim of CBT for HA is to reduce distress, reduce unhelpful safety-seeking 
behaviours and enable consideration of alternative explanations of physical 
sensations that are being misinterpreted as signs of disease (Daniels & Loades, 
2017; Tyrer et al., 2014). 
As with adult HA interventions and good practice in CBT for children and 
young people (Fuggle & Curry, 2012; Stallard, 2002, 2005), assessment and 
formulation is the necessary foundation of individualised treatment. Once a shared 
understanding is reached of how health-related worries manifest, including the 
cyclical nature and the role of safety-seeking behaviours, it is the latter which 
becomes the focus of the intervention. In the COVID-19 context, the intervention 
might also involve a focus on tolerance of uncertainty, and recognition that the 
excessive use of precautionary measures may be increasing rather than decreasing 
anxiety about contracting COVID-19. This will foster an understanding of what 
constitutes necessary precautionary measures which are no more, or no less than 
required (see Table 3). Adaptations must be made to ensure efficacy of treatment for 
children and young people. Rask (2019) suggests that duration and creative content 
of sessions (role play, using cartoons, drawing or using play) should be key 
considerations when adapting a CBT intervention for children, in addition to 
adjustments for cognitive and social developmental stages. This might include 
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simplification of concepts, scaffolding knowledge and emotional literacy through 
increased psychoeducation about both illness and about emotions, including family 
members in treatment, and use of creative, fun activities to engage children and 
young people (Stallard, 2002). Some of the intervention strategies commonly used in 
CBT for HA are conceptually abstract and require cognitive reasoning which would 
require adaptation to stage of cognitive emotional development. 
 
Table 3 
What CBT for Health-Related Worries in Children and Young People in the 
COVID-19 Context Might Involve (Adapted from Tyrer et al., 2011) 
 
Formulation of the young person’s worst fears related to COVID-19, and how this 
fits with family attitudes and behaviours during the pandemic, as well as during 
previous episodes of ill-health 
Introduction to the possibility of alternative explanations of physical symptoms 
e.g. anxiety about COVID-19 is causing significant distress and physiological 
arousal, rather than the young person being ill with COVID-19 
Evaluation of risk of COVID-19, acknowledging the lack of certainty in the context 
of this novel coronavirus 
Consideration of the negative consequences of health anxiety for the young 
person and their family  
Exploration of the hypothesis that fear of COVID-19 is having more of a negative 
impact on the young person than COVID-19 itself 
Identification of residual physical sensations related to anxiety and attentional 
bias for these symptoms 
Reduction and testing of safety seeking behaviours that may be helping to 
maintain health anxiety, e.g. excessive bodily checking (young person) and 
providing excessive reassurance (parents)  
Building resilience in the family to manage COVID-19 difficulties e.g. strategies to 
facilitate home-schooling and maintain a sense of routine, considerations for 
parents working from home, maintaining healthy habits e.g. sleep hygiene, 
healthy eating, exercise 
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How parents might be involved in treatment 
 
 Rask (2019) outlines three fundamental differences between child HA and adult 
HA which point towards a central role of parents/caregivers in the treatment of HA and 
health-related worries in children: 
1. There is a qualitative difference to a child’s thinking processes compared to an 
adult, and they will have a different understanding of illness and disease. 
2. Reassurance seeking will often be directed to adults in the child’s life such as 
parents, caregivers and teachers rather than health professionals. 
3. Maintaining factors will be inextricably linked to the beliefs and psychosocial 
functioning of parents. 
 
While there are differences between HA in adults and in those aged under 18, 
it is also important to consider that there are also likely to be developmental 
differences between children and young people (Waite & Creswell, 2014). For 
example, the child’s age and developmental stage may influence decision-making 
and relevance of parental involvement in therapy. This may be helpful for younger 
children but may actually feel disempowering and inhibit engagement for 
adolescents. It may be that involving parents in some but not all sessions, or at the 
beginning or end of sessions only could be useful in this circumstance. Evidence 
regarding parental involvement in children’s anxiety treatment is mixed. Two recent 
meta-analyses included studies reflecting a wide range of ages (three years to 18 
years) and concluded that parental involvement has little or no impact on outcome 
(Thulin, Svirsky, Serlachius, Andersson, & Ost, 2014; Zhou et al., 2019), whilst other 
studies report that for children aged four to 12, parent-led CBT is effective in treating 
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anxiety (Waters, Ford, Wharton & Cobham, 2009; Cartwright-Hatton et al., 2011; 
Creswell et al., 2017). Parent-led treatment for HA in children could therefore be a 
useful approach and warrants further exploration.  
Creswell and colleagues (2020) suggest that parental involvement is not 
binary; it is the quality of involvement that is important, recommending a nuanced 
approach to involving parents, which may be dependent on the individual formulation 
for that child. There is evidence that involvement of parents in online CBT 
programmes produces significantly larger effect sizes than programmes that do not 
involve parents (Grist, Crocker, Denne & Stallard, 2019). There is also evidence that 
if parental involvement in low-intensity therapy such as bibliotherapy is closely 
supported by a therapist, outcomes are enhanced (Cobham, 2012; Lyneham & 
Rapee, 2006; Thirlwall et al., 2013).  
 
Delivering psychological therapies in the COVID-19 context 
 
Dalton, Rapa and Stein (2020) indicate that it is of utmost importance to talk 
about the pandemic with children and young people in a developmentally appropriate 
manner. This is particularly the case if children and young people experience 
distress related to COVID-19. In the context of lockdown measures, social isolation 
and physical distancing, face-to-face therapy is not practical or safe, therefore it is 
important to consider alternative methods in delivering treatment. There is a body of 
evidence indicating that computerised CBT is effective in child, young people and 
adult populations (Grist, Croker, Denne & Stallard, 2018; Hollis et al., 2017; Newby 
et al., 2020; Olthuis, Watt, Bailey, Hayden & Stewart, 2016; Thew, 2020; Vigerland et 
al., 2016). Evidence also suggests that transdiagnostic online CBT for anxiety in 
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children and young people can be as effective in emergency contexts: in 2012, after 
a series of violent earthquakes in New Zealand, an online therapist-assisted CBT 
package was found to be effective at reducing anxiety (Moor et al., 2019). Moreover, 
many therapists are now delivering CBT via video platforms during the pandemic out 
of necessity. In response to these and other changes, the British Psychological 
Society (2020) have produced guidance on adaptation for this mode of delivery 
which recommends working creatively with children on a video call by utilising screen 
sharing; managing expectations through having a set session format; ensuring 
privacy; being alert to signs of distress and having a plan as to how to respond to 
this remotely. The BPS guidance is also clear that therapy delivered via video may 
not be appropriate for all children and young people.   
In the absence of online HA specific interventions for children and young 
people, adapting existing online evidence-based programmes for anxiety to address 
health-related worries relevant to COVID-19 specifically may hold promise. The 
adaptations needed would include specific content about coronaviruses and COVID-
19, and about concerns children and young people may have about the health threat 
to adults as well as to themselves. This would need to acknowledge the ongoing 
uncertainty about COVID-19 and to include a focus on coping with this uncertainty, 
as well as uncertainty about how long disease containment measures will be in place 
and how they will be lifted. Content and techniques, including practical exercises, 
would need to consider physical distancing and disease containment measures. 
Specific suggestions about how to seek social support and to maintain social contact 
within these limitations may also be helpful. Further research is needed to establish if 
existing transdiagnostic programmes, delivered online, are effective in the pandemic 
context at reducing health-related worries. 
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Conclusion 
 
In the context of a global pandemic, some degree of health-related fear is normal 
and adaptive. However, for a minority of children and young people, this health-
related fear may become particularly distressing. It may interfere substantially with 
their functioning and persist over time, in a way that we recognise in HA. For these 
children and young people, adopting a multi-informant approach to assessment, 
including using existing HA scales to complement clinical interview, could help to 
establish the extent of their HA. An individualised formulation of the problem, 
including the cognitive, behavioural and emotional components, based on the CBT 
model, should be developed. Consideration of developmental factors such as 
cognitive ability, emotional literacy, intergenerational transmission of beliefs and 
parental modelling or reinforcement of behaviours, is an important part of the 
formulation. Adapting existing evidence-based HA treatments for adults and offering 
these to children and young people may be most helpful. More research is needed to 
establish age-appropriate diagnostic criteria and standardised tools for assessment 
of HA in younger children, and to evaluate developmentally appropriate treatment 
intervention/programmes. 
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Key practitioner messages: 
 
- Raised health-related worries during the COVID-19 pandemic are normal and 
do not necessarily require treatment 
- For some, the level of anxiety experienced during the pandemic may be 
understood in terms of HA, which is treatable using cognitive behavioural 
models 
- Although the majority of research into HA focusses on adults, evidence 
suggests that children and young people also develop health-related worries 
and HA, and may be particularly susceptible during global health crises  
- When treating HA in children and young people, it is important to make 
development adaptations and consider involvement of parents in treatment  
- Given the current government mandated measures to manage the spread of 
COVID-19, alternatives to face-to-face treatment should be considered such 
as internet-delivered CBT  
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